The approval of Mounjaro is an exciting step forward for people living with type 2 diabetes given the results seen in these clinical trials," said Juan Pablo Fras, M.D., Medical Director, Mounjaro will be available in six doses (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg) and will come in The approval was based on results from the phase 3 SURPASS program, which included active comparators of injectable semaglutide 1 mg, insulin glargine and insulin degludec
Track orders, update preferences, and access your complete purchase history for a seamless research experience
Who Is a Good Candidate for Medical Weight Loss in San Jose
doi:10.2174/0929867324666170608111917 Zaki SM, Abdalla IL, Sadik AOE, Mohamed EA, Kaooh S
, ,